134 related articles for article (PubMed ID: 6500947)
1. Dose estimation to the infant from breast milk following intraperitoneal administration of chromic phosphate 32P for the treatment of early ovarian cancer.
Sharma SC; Osborne RP; Jose B; Carlson JA
Health Phys; 1984 Sep; 47(3):452-4. PubMed ID: 6500947
[No Abstract] [Full Text] [Related]
2. Radioactivity in breast milk after intraperitoneal chromic phosphate for the treatment of early ovarian cancer.
Carlson JA; Jose B; Sharma SC; Osborne RP
Am J Obstet Gynecol; 1983 Dec; 147(7):840-1. PubMed ID: 6650612
[No Abstract] [Full Text] [Related]
3. Intraperitoneal radioactive chromic phosphate (P32) in the treatment of ovarian cancer.
Powell JL; Kirchner AB
J Med Assoc Ga; 1984 Jan; 73(1):21-5. PubMed ID: 6707541
[No Abstract] [Full Text] [Related]
4. Intraperitoneal chromic phosphate in ovarian cancer: risks and benefits.
Potter ME; Partridge EE; Shingleton HM; Soong SJ; Kim RY; Hatch KD; Austin JM
Gynecol Oncol; 1989 Mar; 32(3):314-8. PubMed ID: 2920951
[TBL] [Abstract][Full Text] [Related]
5. Effects of injection volume on the tissue dose, dose rate, and therapeutic potential intraperitoneal 32p.
Leichner PK; Cash SA; Backx C; Durand RE
Radiology; 1981 Oct; 141(1):193-9. PubMed ID: 7291525
[TBL] [Abstract][Full Text] [Related]
6. [Intraperitoneal irradiation in limited epithelial neoplasms of the ovary. Review of the literature].
Wolff JP; Burini GA
Minerva Ginecol; 1985; 37(7-8):407-13. PubMed ID: 3906441
[No Abstract] [Full Text] [Related]
7. Intraperitoneal radioactive chromic phosphate P 32 in the treatment of ovarian cancer.
Powell JL; Burrell MO; Kirchner AB
South Med J; 1987 Dec; 80(12):1513-7. PubMed ID: 3423895
[TBL] [Abstract][Full Text] [Related]
8. Intraperitoneal radioactive phosphate in early ovarian carcinoma: an analysis of complications.
Walton LA; Yadusky A; Rubinstein L
Int J Radiat Oncol Biol Phys; 1991 May; 20(5):939-44. PubMed ID: 2022522
[TBL] [Abstract][Full Text] [Related]
9. Five and ten year estimated survival and disease-free rates after intraperitoneal chromic phosphate; stage I ovarian adenocarcinoma.
Piver MS; Lele SB; Bakshi S; Parthasarathy KL; Emrich LJ
Am J Clin Oncol; 1988 Oct; 11(5):515-9. PubMed ID: 3177251
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant internal hepatic radiotherapy using colloidal 32P chromic phosphate in colorectal cancer.
Kim JY; Bom HS; Kim YJ; Choi W
Radiat Med; 1990; 8(6):246-9. PubMed ID: 2093946
[TBL] [Abstract][Full Text] [Related]
11. Phosphorus-32-chromic phosphate for ovarian cancer: I. Fractionated low-dose intraperitoneal treatments in conjunction with platinum analog chemotherapy.
Pattillo RA; Collier BD; Abdel-Dayem H; Ozker K; Wilson C; Ruckert AC; Hamilton K
J Nucl Med; 1995 Jan; 36(1):29-36. PubMed ID: 7799078
[TBL] [Abstract][Full Text] [Related]
12. Pleuroperitoneal migration of intraperitoneal phosphorus-32-chromic phosphate therapy for stage I ovarian carcinoma.
Wilkinson RH
J Nucl Med; 1996 Apr; 37(4):636-9. PubMed ID: 8691256
[TBL] [Abstract][Full Text] [Related]
13. Radioactive chromic phosphate suspension: studies on distribution, dose absorption, and effective therapeutic radiation in phantoms, dogs, and patients.
Currie JL; Bagne F; Harris C; Sullivan DL; Surwit EA; Wilkinson RH; Creasman WT
Gynecol Oncol; 1981 Oct; 12(2 Pt 1):193-218. PubMed ID: 7297930
[No Abstract] [Full Text] [Related]
14. Distribution and tissue dose of intraperitoneally administered radioactive chromic phosphate (32P) in New Zealand white rabbits.
Leichner PK; Rosenshein NB; Leibel SA; Order SE
Radiology; 1980 Mar; 134(3):729-34. PubMed ID: 7355227
[TBL] [Abstract][Full Text] [Related]
15. Bowel perforation associated with intraperitoneal chromic phosphate instillation.
Proctor J; Doering D; Barnhill D; Park R
Gynecol Oncol; 1990 Jan; 36(1):125-7. PubMed ID: 2295443
[TBL] [Abstract][Full Text] [Related]
16. Update on the role of radiotherapy in ovarian cancer.
Lanciano R; Reddy S; Corn B; Randall M
Semin Oncol; 1998 Jun; 25(3):361-71. PubMed ID: 9633849
[No Abstract] [Full Text] [Related]
17. Intraperitoneal distribution of 32P-chromic phosphate suspension in the dog.
Tewfik HH; Gruber H; Tewfik FA; Lifshitz SG
Int J Radiat Oncol Biol Phys; 1979 Oct; 5(10):1907-13. PubMed ID: 528257
[No Abstract] [Full Text] [Related]
18. Phosphorus-32-colloidal chromic phosphate: treatment of choice for malignant pericardial effusion.
Sprengelmeyer JT; McDermott RL
J Nucl Med; 1990 Dec; 31(12):2034-6. PubMed ID: 2266403
[TBL] [Abstract][Full Text] [Related]
19. Intraperitoneal chromic phosphate in peritoneoscopically confirmed stage I ovarian adenocarcinoma.
Piver MS; Barlow JJ; Lele SB; Bakshi S; Parthasarathy KL; Bender MA
Am J Obstet Gynecol; 1982 Dec; 144(7):836-40. PubMed ID: 6216811
[TBL] [Abstract][Full Text] [Related]
20. Unit dose dispensing of chromic phosphate P 32 suspension.
Hung JC
Am J Hosp Pharm; 1994 Dec; 51(24):3081. PubMed ID: 7856633
[No Abstract] [Full Text] [Related]
[Next] [New Search]
